Mach7 Technologies (ASX:M7T) EBIT : A$-21.57 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mach7 Technologies EBIT?

Mach7 Technologies's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$-5.77 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-21.57 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Mach7 Technologies's annualized ROC % for the quarter that ended in Dec. 2023 was -17.41%. Mach7 Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -610.10%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -15.96%.

Mach7 Technologies EBIT Historical Data

The historical data trend for Mach7 Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mach7 Technologies EBIT Chart

Mach7 Technologies Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

Get a 7-Day Free Trial

-7.78

-0.55

-11.59

-6.28

-17.17

Mach7 Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-1.48	-4.80	-1.37	-15.80	-5.77

Competitive Comparison of Mach7 Technologies's EBIT

For the Health Information Services subindustry, Mach7 Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mach7 Technologies's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mach7 Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Mach7 Technologies's EV-to-EBIT falls into.

Mach7 Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-21.57 Mil.

Mach7 Technologies (ASX:M7T) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Mach7 Technologies's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-11.54 * ( 1 - 16.22% )	/	( (58.849	+	52.228)	/ 2 )
=	-9.668212	/	55.5385
=	-17.41 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	82.306	-	3.398	-	( 23.395	-	max(0, 14.831	-	34.89	+	23.395	))
=	58.849

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	73.788	-	2.439	-	( 22.729	-	max(0, 12.579	-	31.7	+	22.729	))
=	52.228

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Mach7 Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-11.54	/	( ( (1.997 + max(-3.214, 0))	+	(1.786 + max(-3.394, 0)) )	/	2 )
=	-11.54	/	( ( 1.997	+	1.786 )	/	2 )
=	-11.54	/	1.8915
=	-610.10 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.619	+	0	+	4.788)	-	(3.398	+	11.224	+	-0.0010000000000012)
=	-3.214

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.771	+	0	+	4.2)	-	(2.439	+	0	+	9.926)
=	-3.394

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Mach7 Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-21.567	/	135.146
	=	-15.96 %

Mach7 Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Mach7 Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Mach7 Technologies (ASX:M7T) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mach7 Technologies Ltd (ASX:M7T) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403

Website

https://www.mach7t.com

Mach7 Technologies Ltd is engaged in enterprise imaging data sharing, storage, and interoperability for healthcare enterprises globally. The principal activity of the Company is the development and commercialisation of medical imaging and data, management software solutions for global healthcare enterprises The company's operating segment includes Software licenses and Professional services. It generates maximum revenue from the Software licenses segment. Geographically, it derives a majority of its revenue from North America and also has a presence in the Middle East; Asia/Pacific and Europe, and other regions. The company's solutions include Management Studio; Diagnostic Studio; and Clinical Studio.

Mach7 Technologies (ASX:M7T) Headlines

No Headlines